CMB 1.20% 42.0¢ cambium bio limited

Ann: Regeneus signs MOU with Kyocera Corporation, page-20

  1. 172 Posts.
    lightbulb Created with Sketch. 52
    So this misleading info comes from Finfeed then... because in the original paper refered to, no mention of Progenza or any anti-inflammatory treatment.
    https://www.sciencedirect.com/science/article/pii/S0140673620303007

    This doesn't mean Progenza is not suited for ARDS, but it's far from becoming a treatment for Covid.

 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.